RamSoft announced its partnership with Digisonics to offer integrated, vendor-neutral cardiac post-processing and structured reporting for all cardiovascular modalities. Digisonics was recently named Best in KLAS for the Cardiology market segment for the fifth consecutive year.

According to Millennium Research Group (MRG), approximately 80 percent of transcatheter aortic valve replacement (TAVR) procedures are being performed on high-risk patients who are ineligible for surgical heart valve replacement. New clinical evidence that supports TAVR in treatment of intermediate and high-risk operable patients has led to expanded reimbursement for a new patient base for the procedure.

Merge Healthcare Inc. announced that Merge Hemo has been named the "Category Leader" in the "2012 Best in KLAS Awards: Software & Services" report for Cardiology Hemodynamics rankings for the second consecutive year.

Cerebral Angioplasty Stents Radiology Stroke treatment devices

Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.

The first patient has been implanted with the Boston Scientific Corporation next generation Ingevity pacing leads in a clinical trial designed to establish the safety, performance and effectiveness of the leads. Pacing leads are insulated wires that connect an implantable pacemaker to the heart for treatment of bradycardia, a condition in which the heart beats too slowly, depriving the body of sufficient oxygen. Pacemakers work in conjunction with leads to sense and stimulate (or pace) the heart, thus maintaining an appropriate heart rate for a given level of physical activity.

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors associated with a higher prevalence of the disease including older age, lower educational level and prior diagnoses of dyslipidemia, hypertension and obesity, according to a clinical study in the Dec. 26 issue of JAMA.

Pulse Oximetry Screening is a life-saving test that can detect critical congenital heart defects (CCHD) in newborn babies before an infant is discharged from the hospital. The test is easy to perform, however, appropriate interpretation of the results can be challenging. In order to aid health care providers in interpreting the results of the screening, Children's Healthcare of Atlanta has created the Pulse Ox Tool, a ground-breaking app for smart phones that automates the Pulse Oximetry Screening test and improves the accuracy of detecting children with possible CCHD.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now